Also, the level of TNF-α, IL-6, and IL-1β in the serum of FD patients could activate mast cells in the gastric mucosa, thereby contributing to impaired GI motility and altered visceral sensation [26]. The gene discussed is IL1B; the disease is Fabry disease.